Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness

By Da Villa G.   Sepe A.  

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1734-1738

Elsevier

Access to resources Recommend Favorite

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

By Isaka M.   Yasuda Y.   Mizokami M.   Kozuka S.   Taniguchi T.   Matano K.   Maeyama J.-i.   Mizuno K.   Morokuma K.   Ohkuma K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1460-1466

Elsevier

Access to resources Recommend Favorite

Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction

By Kato H.   Nakata K.   Hamasaki K.   Hida D.   Ishikawa H.   Aritomi T.   Nakao K.   Kato Y.   Yano M.   Eguchi K.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 581-587

Elsevier

Access to resources Recommend Favorite

Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

By Hu G.-J.   Wang R.Y.-H.   Han D.-S.   Alter H.J.   Shih J.W.-K.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3160-3170

Elsevier

Access to resources Recommend Favorite

Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial

By Ugen K.E.   Boyer J.D.   Wang B.   Bagarazzi M.   Javadian A.   Frost P.   Merva M.M.   Agadjanyan M.G.   Nyland S.   Williams W.V.   Coney L.   Ciccarelli R.   Weiner D.B.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 927-930

Elsevier

Access to resources Recommend Favorite